Cargando…
Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
Rationale: Patients suffering from coronary artery disease (CAD) complicated with nonalcoholic fatty liver disease (NAFLD) present worse cardiovascular outcomes than CAD patients without NAFLD. The progression of CAD is recently reported to be associated with gut microbiota and microbe-derived metab...
Autores principales: | Hu, Xiaomin, Zhou, Ruilin, Li, Hanyu, Zhao, Xinyue, Sun, Yueshen, Fan, Yue, Zhang, Shuyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761954/ https://www.ncbi.nlm.nih.gov/pubmed/35047580 http://dx.doi.org/10.3389/fcvm.2021.805812 |
Ejemplares similares
-
The Effects of Moderate Alcohol Consumption on Circulating Metabolites and Gut Microbiota in Patients With Coronary Artery Disease
por: Zhao, Xinyue, et al.
Publicado: (2021) -
Impacts of Cigarette Smoking Status on Metabolomic and Gut Microbiota Profile in Male Patients With Coronary Artery Disease: A Multi-Omics Study
por: Hu, Xiaomin, et al.
Publicado: (2021) -
Multi-omics study reveals that statin therapy is associated with restoration of gut microbiota homeostasis and improvement in outcomes in patients with acute coronary syndrome
por: Hu, Xiaomin, et al.
Publicado: (2021) -
Alterations in the gut microbiome and metabolism with coronary artery disease severity
por: Liu, Honghong, et al.
Publicado: (2019) -
The role of the gut microbiome and exercise in non-alcoholic fatty liver disease
por: Houttu, Veera, et al.
Publicado: (2020)